UBE2R2-AS1

Across TCGA pan-cancer cohorts, UBE2R2-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated UBE2R2-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher UBE2R2-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBE2R2-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCS show a favorable association.

KIRC, BLCA, and LIHC are the cancer types where UBE2R2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.546	0.694	<.001	89	view →
BLCA	OS	Quartile	II,III,IV	0.578	0.329	<.001	61	view →
LIHC	DFS	Quartile	All	0.333	0.483	.002	51	view →
ACC	DFS	Tertile	All	0.401	0.745	.001	50	view →
UCEC	DFS	Tertile	All	0.489	0.793	.003	42	view →
LUSC	OS	Median	III,IV	0.251	0.536	.002	37	view →
KIRP	DFS	Quartile	All	0.484	0.893	<.001	24	view →
UCS	DFS	Tertile	III,IV	0.481	0.277	.026	18	view →
CHOL	OS	Median	III,IV	1.000	0.286	.008	15	view →
STAD	OS	Quartile	III,IV	0.790	0.350	.020	14	view →
UVM	DFS	Median	III,IV	0.208	0.740	.006	12	view →
THCA	DFS	Quartile	II,III,IV	0.827	0.976	.007	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

UBE2R2-AS1–KIRC (OS)

Open the KIRC breakdown →